InsidersTradesSigma
Track the 경동제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 경동제약 has recorded 1 insider filings. Market capitalisation: €142.1bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 류 기 성. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
경동제약 es una empresa del sector de la salud y farmacéutico, cotizada en la bolsa XKRX. Se centra en la investigación, desarrollo y fabricación de productos farmacéuticos.